The “IMMediate – Immune-Mediated Diseases” program at the Medical Center – University of Freiburg is based in the fields of immunology, oncology and cell biology. It supports Advanced Clinician Scientists who examine immune-mediated diseases that affect e.g. the brain, heart, liver or intestine.
“With the generous funding of 9.3 million euros, we will be able to create protected research time (50%) for 12 specialist and senior physicians over the next five years. This gives them more freedom for their research activities”, says Prof. Dr. Robert Thimme (A02), Medical Director of the Clinic for Internal Medicine II (gastroenterology, hepatology, endocrinology, infectious diseases) at the University Medical Center Freiburg and IMMediate project leader. Thimme submitted the successful application together with Prof. Dr. Stephan Ehl (A01), Director of the Institute for Immunodeficiency at the University Medical Center Freiburg, and Prof. Dr. Leena Bruckner-Tuderman, Medical Director of the Clinic for Dermatology and Venereology at the University Medical Center Freiburg.
The program, which was the only project in Baden-Württemberg to receive funding, strengthens the excellent framework conditions for scientists at the Medical Faculty of the Albert Ludwig University of Freiburg. “I am pleased that we can further expand the structured training program for medical professionals in Freiburg with IMMediate. It started with MOTI-VATE in medical studies. Together with the Berta-Ottenstein program and now with IMMediate, all phases of medical training up to long-term career prospects are covered”, says Thimme.
Background:
At the university hospitals in Germany, medical research and patient treatment are closely linked. This link is a central feature of university medicine. It enables university hospitals to significantly advance health research and to transfer important advances quickly into treatment. With the funding initiative, the Federal Ministry of Education and Research wants to ensure that doctors at an intermediate stage of their academic career have the best framework conditions for their research.
